![Jodi Cook](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Jodi A. Cook is President & Chief Executive Officer at Skylark Bio, Inc. since 2022.
Dr. Cook is an Independent Director at Fennec Pharmaceuticals, Inc. since 2019.
Former roles include Audiology Director at Songbird Holdings LLC, Director-Hearing Aid Program at Mayo Clinic, Vice President-Clinical Research at InSound Medical, Inc., Head-Gene Therapy Strategy at PTC Therapeutics, Inc., and Chief Operating Officer at PTC Therapeutics GT, Inc. Education includes a doctorate from Arizona State University, an undergraduate degree from Loyola University Maryland, Inc., and a graduate degree from the University of South Carolina.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| FENNEC PHARMACEUTICALS INC. | Direttore/Membro del Consiglio | 24/09/2019 |
Skylark Bio, Inc.
 Skylark Bio, Inc. BiotechnologyHealth Technology Develops gene therapy solutions for neurology and hearing impairment | Amministratore Delegato | 01/12/2022 |
| Società | Posizione | Fine |
|---|---|---|
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2020 |
Songbird Holdings LLC
 Songbird Holdings LLC Medical SpecialtiesHealth Technology Designs and manufactures hearing devices | Corporate Officer/Principal | - |
InSound Medical, Inc.
 InSound Medical, Inc. Medical SpecialtiesHealth Technology Develops and manufactures hearing devices | Corporate Officer/Principal | - |
Mayo Clinic
 Mayo Clinic Medical/Nursing ServicesHealth Services Operates medical clinics and hospitals | Corporate Officer/Principal | - |
PTC Therapeutics GT, Inc.
 PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Innovates DNA therapeutics, provides long-term efficacy for patients with debilitating & fata diseases | Direttore operativo | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Fennec Pharmaceuticals, Inc.
 Fennec Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutic products which dedicated to improving the lives of children with cancer who experience hearing loss | Health Technology |
InSound Medical, Inc.
InSound Medical, Inc. Medical SpecialtiesHealth Technology Develops and manufactures hearing devices | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Arizona State University
 Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola University Maryland, Inc.
 Loyola University Maryland, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Carolina
 University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Songbird Holdings LLC
Songbird Holdings LLC Medical SpecialtiesHealth Technology Designs and manufactures hearing devices | Health Technology |
Mayo Clinic
Mayo Clinic Medical/Nursing ServicesHealth Services Operates medical clinics and hospitals | Health Services |
PTC Therapeutics GT, Inc.
PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Innovates DNA therapeutics, provides long-term efficacy for patients with debilitating & fata diseases | Health Technology |
Skylark Bio, Inc.
Skylark Bio, Inc. BiotechnologyHealth Technology Develops gene therapy solutions for neurology and hearing impairment | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
